Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou LBP Medicine Science & Technology has commercialized a broad portfolio of in vitro diagnostic products for pathology departments. Their offerings include liquid-based cytology systems for cell morphology analysis, PCR kits for genetic testing (e.g., HPV), immunohistochemistry reagents/equipment for protein expression analysis, FISH kits/instruments for chromosomal/gene detection, and digital pathology solutions. Many products have received CE certification and approvals from international regulatory bodies[2]. The company serves both domestic Chinese hospitals and some overseas markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou LBP Medicine Science & Technology.